VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Misses Revenue Estimates

Published on 13 Feb 2025 on Zacks · via Yahoo Finance

VistaGen Therapeutics (VTGN) delivered earnings and revenue surprises of 8% and 35%, respectively,...

Read the rest of the article

Start tracking your investments with Statfolio

VistaGen Therapeutics (VTGN) delivered earnings and revenue surprises of 8% and 35%, respectively...

Zacks · via Yahoo Finance 13 Feb 2025

Despite increased expenses and net loss, Vistagen Therapeutics Inc (VTGN) advances its neuroscien...

GuruFocus.com · via Yahoo Finance 8 Nov 2024

Vistagen Therapeutics Inc (NASDAQ:VTGN) is set to release its Q2 2025 earnings on Nov 7, 2024. Th...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

<img src=https://s.yimg.com/ny/api/res/1.2/pwE7Szs5QbExfXOFTuzKjg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyM...

GuruFocus.com · via Yahoo Finance 6 Oct 2024

Vistagen Therapeutics (NASDAQ:VTGN) Full Year 2024 Results Key Financial Results Net loss: US$29....

Simply Wall St. · via Yahoo Finance 19 Jun 2024

Vistagen Therapeutics (NASDAQ:VTGN) Third Quarter 2024 Results Key Financial Results Net loss:...

Simply Wall St. · via Yahoo Finance 21 Feb 2024

Shares of VistaGen Therapeutics, Inc. (VTGN) have gained 1% over the past four weeks to close the...

Zacks via Yahoo Finance 21 Feb 2024

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2024 Earnings Call Transcript February 13, 2024 Vist...

Insider Monkey via Yahoo Finance 15 Feb 2024

<img src=https://s.yimg.com/ny/api/res/1.2/pwE7Szs5QbExfXOFTuzKjg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyM...

GuruFocus.com via Yahoo Finance 13 Feb 2024

One stock that might be an intriguing choice for investors right now is Vistagen Therapeutics, In...

Zacks via Yahoo Finance 29 Dec 2023